Skip to main content
NRXP
NASDAQ Life Sciences

FDA Grants Expanded Access for NRX-101 to Treat Depression, Augmenting TMS

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$3.98
Mkt Cap
$166.515M
52W Low
$1.62
52W High
$5.055
52W Position info
146% above low
Off High info
21% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

NRXP has more than doubled off its 52-week low of $1.62.

Summary

The FDA has granted NRx Pharmaceuticals an Expanded Access Protocol (EAP) for its drug NRX-101, allowing its use to augment Transcranial Magnetic Stimulation (TMS) in treating depression. This EAP provides early access to NRX-101 for patients with serious conditions while pivotal clinical trials are underway. The move is a positive regulatory signal, offering a regulated and stable D-cycloserine-based therapy, which addresses concerns about compounded versions. This follows recent positive FDA interactions for the company's pipeline, though it also comes after a dilutive $20 million public offering and a 'going concern' warning in Q1.

At the time of this announcement, NRXP was trading at $3.98 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $166.5M. The 52-week trading range was $1.62 to $5.06. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

NRXP - Latest Insights

NRXP
Nov 17, 2026, 7:18 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.10
Real-time Price: $2.73 info
Change: +$0.630 (+30%) info
Market Cap: $120.794M info
NRXP
Oct 30, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $2.98
Real-time Price: $2.73 info
Change: -$0.2498 (-8%) info
Market Cap: $120.794M info
NRXP
Oct 15, 2026, 8:27 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $2.55
Real-time Price: $2.73 info
Change: +$0.180 (+7%) info
Market Cap: $120.794M info
NRXP
Oct 05, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.86
Real-time Price: $2.73 info
Change: -$0.130 (-5%) info
Market Cap: $120.794M info
NRXP
Sep 30, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $2.98
Real-time Price: $2.73 info
Change: -$0.2545 (-9%) info
Market Cap: $120.794M info